Haemonetics Corp. (HAE)
79.22
+0.51
(+0.65%)
USD |
NYSE |
Jun 10, 14:38
Haemonetics EPS Diluted (Quarterly) : -0.4359 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | -0.06 |
| Boston Scientific Corp. | 0.897 |
| QuidelOrtho Corp. | -1.346 |
| Globus Medical, Inc. | 0.8995 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.15M |
| Revenue (Quarterly) | 346.35M |
| Total Expenses (Quarterly) | 366.50M |
| Enterprise Value | 4.591B |
| Gross Profit Margin (Quarterly) | 54.21% |
| Profit Margin (Quarterly) | -5.82% |
| Earnings Yield | 2.56% |
| Operating Earnings Yield | 6.50% |
| Normalized Earnings Yield | 4.264 |